Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
42.23B | 43.45B | 46.30B | 51.76B | 47.26B | 43.64B | Gross Profit |
9.46B | 9.60B | 9.91B | 11.64B | 10.57B | 10.05B | EBIT |
1.79B | 1.57B | 1.79B | 3.04B | 2.39B | 2.01B | EBITDA |
2.70B | 2.60B | 2.86B | 3.88B | 3.51B | 2.87B | Net Income Common Stockholders |
1.27B | 1.24B | 1.42B | 2.45B | 1.80B | 1.54B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.45B | 1.45B | 1.87B | 2.94B | 5.49B | 2.23B | Total Assets |
14.97B | 14.97B | 15.80B | 17.50B | 19.07B | 15.59B | Total Debt |
3.98B | 3.98B | 3.98B | 3.94B | 4.08B | 4.07B | Net Debt |
2.54B | 2.54B | 2.10B | 1.00B | -1.41B | 1.84B | Total Liabilities |
11.91B | 11.91B | 13.01B | 14.48B | 14.48B | 12.11B | Stockholders Equity |
3.05B | 3.05B | 2.79B | 3.02B | 4.59B | 3.48B |
Cash Flow | Free Cash Flow | ||||
1.03B | 675.00M | 894.00M | 2.52B | 4.21B | 1.82B | Operating Cash Flow |
1.74B | 1.47B | 1.82B | 3.25B | 4.93B | 2.56B | Investing Cash Flow |
-703.00M | -781.00M | -962.00M | -1.37B | -788.00M | -895.00M | Financing Cash Flow |
-1.16B | -1.14B | -1.81B | -4.30B | -876.00M | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $2.16T | 36.91 | 20.72% | ― | 10.99% | 91.61% | |
78 Outperform | $460.27B | 60.89 | 30.98% | 0.44% | 5.35% | 16.22% | |
77 Outperform | $762.93B | 39.41 | 22.33% | 0.85% | 5.07% | 25.86% | |
70 Outperform | $53.67B | 12.41 | 30.16% | 3.69% | 0.64% | 20.16% | |
67 Neutral | $18.54B | 14.82 | 41.21% | 4.33% | -3.02% | 1.21% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% |